Adapthealth Corp Stock Price, News & Analysis

AdaptHealth Corp. (NASDAQ: AHCO), a national leader in healthcare-at-home solutions, has announced its participation in two upcoming investor conferences. The company will attend the Barclays Leveraged Finance Conference in Austin on May 20, 2025, and the RBCCM Global Healthcare Conference in New York on May 21, 2025, where they will participate in a fireside chat at 8:00 a.m. ET.

AdaptHealth operates across four segments: Sleep Health, Respiratory Health, Diabetes Health, and Wellness at Home, serving approximately 4.2 million patients annually through 660 locations in 47 states. The company partners with various healthcare providers and serves beneficiaries of Medicare, Medicaid, and commercial insurance payors.

AdaptHealth Corp. (NASDAQ: AHCO) reported its Q1 2025 financial results, showing mixed performance. Net revenue decreased 1.8% to $777.9 million compared to $792.5 million in Q1 2024. The company reported a net loss of $7.2 million, wider than the $2.1 million loss in the previous year. Adjusted EBITDA declined 19.3% to $127.9 million. However, cash flow from operations improved to $95.5 million from $49.0 million. The company announced the sale of certain incontinence assets and signed an agreement to sell infusion assets from its Wellness at Home segment. Due to these dispositions, AdaptHealth updated its FY2025 guidance, now expecting revenue of $3.18-3.32 billion and Adjusted EBITDA of $665-705 million. The company serves approximately 4.2 million patients across 50 states through 660 locations.

AdaptHealth (NASDAQ: AHCO), a national leader in patient-centered healthcare-at-home solutions, has scheduled its first quarter 2025 financial results announcement for Tuesday, May 6, 2025, before market open.

The company will host an analyst and investor conference call at 8:30 a.m. ET to discuss quarterly results and business activities. Participants can join via phone using the numbers (800) 343-5172 (Domestic) or (203) 518-9856 (International) with Conference ID: AHCO1Q25. A webcast option is also available, and a replay will be accessible on the company's website for six months following the live call.

AdaptHealth Corp. (NASDAQ: AHCO), a national leader in healthcare-at-home solutions, has announced its participation in three major investor conferences in Miami this March 2025:

• Jefferies Value-Based Healthcare Summit on March 10 (fireside chat at 3:45pm ET)
• Leerink Partners Global Healthcare Conference on March 11 (fireside chat at 11:20am ET)
• Barclays 27th Annual Global Healthcare Conference on March 12 (fireside chat at 11:30am ET)

AdaptHealth operates across four segments: Sleep Health (sleep therapy equipment), Respiratory Health (oxygen and ventilation equipment), Diabetes Health (medical devices), and Wellness at Home (medical equipment and services). The company serves approximately 4.2 million patients annually across all 50 states through 660 locations in 47 states, partnering with Medicare, Medicaid, and commercial insurance payors.

AdaptHealth Corp. (NASDAQ: AHCO) announced its fourth quarter and full-year 2024 results along with its 2025 outlook. For full-year 2024, the company reported net revenue of $3.26 billion (up 1.9%), net income of $90.4 million (compared to a loss of $678.9 million in 2023), and Adjusted EBITDA of $688.7 million (up 2.7%). Cash flow from operations increased to $541.8 million, with free cash flow of $235.8 million.

Fourth quarter 2024 results showed a slight revenue decrease of 0.2% to $856.6 million, while net income was $50.3 million compared to a loss in Q4 2023. The company reached an agreement to sell certain incontinence assets in its Wellness at Home segment.

For fiscal year 2025, AdaptHealth provided guidance of:

• Net revenue of $3.22 billion to $3.36 billion
• Adjusted EBITDA of $670 million to $710 million
• Free cash flow of $180 million to $220 million

CEO Suzanne Foster highlighted progress on the company's strategic initiatives, including the One Adapt initiative, AI application, increasing clinical relevance, organic growth, and balance sheet strengthening.

AdaptHealth Corp. (NASDAQ: AHCO), a national provider of healthcare-at-home solutions, has scheduled its fourth quarter and full year 2024 financial results announcement for Tuesday, February 25, 2025, before market open. The company will host a conference call at 8:30 a.m. ET for analysts and investors to discuss results and business activities.

Participants can join the call using the following dial-in numbers: (800) 245-3047 (Domestic) or (203) 518-9765 (International), with Conference ID: AHCO4Q24. A webcast replay will be available on AdaptHealth's website under 'Investor Relations' for six months following the live call.

AdaptHealth Corp. (NASDAQ: AHCO) announced the appointment of Russell Schuster as Chief Commercial Officer, effective December 2nd, 2024. Schuster will oversee commercial strategy and revenue generation.

He brings over 25 years of experience, most recently serving as President of Cardinal Health Canada, where he improved performance significantly. His background includes roles in Corporate Development, Business Development, and Strategy at Cardinal Health, as well as positions in Investment Banking and M&A at Lehman Brothers, Barclays Capital, and Republic Services. He began his career as a CPA and Consultant with Ernst & Young.

Suzanne Foster, CEO of AdaptHealth, expressed confidence in Schuster's ability to drive growth and enhance patient care. AdaptHealth provides home medical equipment, medical supplies, and related services, reaching approximately 4.2 million patients annually in all 50 states through 670 locations.

AdaptHealth Corp. (NASDAQ: AHCO) has announced its participation in the BofA Securities Home Care Conference 2024, scheduled for Monday, December 9, 2024. The company will engage in a fireside chat at 1:20pm ET during the virtual event. The webcast will be accessible through AdaptHealth's website under the Investor Relations section.

AdaptHealth is a leading provider of healthcare-at-home solutions, serving approximately 4.2 million patients annually across all 50 states through 670 locations in 47 states. The company specializes in home medical equipment, medical supplies, and related services, including sleep therapy equipment, diabetes care supplies, oxygen therapy, and various medical devices for chronically ill patients.

AdaptHealth Corp. (NASDAQ: AHCO), a national leader in healthcare-at-home solutions, announced its participation in the Stifel 2024 Healthcare Conference in New York on November 19, 2024. The company will engage in a fireside chat at 8:00am ET, with the webcast available on their website.

AdaptHealth provides comprehensive home medical equipment, supplies, and services, serving approximately 4.2 million patients across all 50 states through 670 locations in 47 states. Their offerings include sleep therapy equipment, diabetes medical devices, home medical equipment for post-acute care patients, oxygen therapy services, and supplies for chronic conditions including wound care, urological, and nutritional needs.